nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—ALB—Auranofin—psoriatic arthritis	0.352	0.421	CbGbCtD
Valsartan—SLCO1B3—Methotrexate—psoriatic arthritis	0.176	0.211	CbGbCtD
Valsartan—ALB—Prednisone—psoriatic arthritis	0.112	0.134	CbGbCtD
Valsartan—SLCO1B1—Methotrexate—psoriatic arthritis	0.103	0.123	CbGbCtD
Valsartan—ALB—Methotrexate—psoriatic arthritis	0.0562	0.0672	CbGbCtD
Valsartan—CYP2C9—Dexamethasone—psoriatic arthritis	0.0377	0.045	CbGbCtD
Valsartan—Losartan—ACE—psoriatic arthritis	0.00241	1	CrCbGaD
Valsartan—Angioedema—Prednisolone—psoriatic arthritis	0.000505	0.00315	CcSEcCtD
Valsartan—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000498	0.0031	CcSEcCtD
Valsartan—Vertigo—Prednisolone—psoriatic arthritis	0.000497	0.00309	CcSEcCtD
Valsartan—Syncope—Prednisolone—psoriatic arthritis	0.000496	0.00309	CcSEcCtD
Valsartan—Back pain—Triamcinolone—psoriatic arthritis	0.000492	0.00306	CcSEcCtD
Valsartan—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000486	0.00303	CcSEcCtD
Valsartan—Angiopathy—Dexamethasone—psoriatic arthritis	0.000481	0.00299	CcSEcCtD
Valsartan—Angiopathy—Betamethasone—psoriatic arthritis	0.000481	0.00299	CcSEcCtD
Valsartan—Alopecia—Dexamethasone—psoriatic arthritis	0.000468	0.00292	CcSEcCtD
Valsartan—Alopecia—Betamethasone—psoriatic arthritis	0.000468	0.00292	CcSEcCtD
Valsartan—Angioedema—Triamcinolone—psoriatic arthritis	0.000465	0.00289	CcSEcCtD
Valsartan—Haemoglobin—Prednisone—psoriatic arthritis	0.000464	0.00289	CcSEcCtD
Valsartan—Angioedema—Methylprednisolone—psoriatic arthritis	0.000464	0.00289	CcSEcCtD
Valsartan—Haemorrhage—Prednisone—psoriatic arthritis	0.000462	0.00287	CcSEcCtD
Valsartan—Vertigo—Triamcinolone—psoriatic arthritis	0.000457	0.00284	CcSEcCtD
Valsartan—Syncope—Triamcinolone—psoriatic arthritis	0.000456	0.00284	CcSEcCtD
Valsartan—Vertigo—Methylprednisolone—psoriatic arthritis	0.000456	0.00284	CcSEcCtD
Valsartan—Syncope—Methylprednisolone—psoriatic arthritis	0.000455	0.00283	CcSEcCtD
Valsartan—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000454	0.00282	CcSEcCtD
Valsartan—Oedema—Prednisolone—psoriatic arthritis	0.000451	0.00281	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000451	0.00281	CcSEcCtD
Valsartan—Neutropenia—Methotrexate—psoriatic arthritis	0.000451	0.00281	CcSEcCtD
Valsartan—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000448	0.00279	CcSEcCtD
Valsartan—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000447	0.00278	CcSEcCtD
Valsartan—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000446	0.00278	CcSEcCtD
Valsartan—Shock—Prednisolone—psoriatic arthritis	0.000444	0.00276	CcSEcCtD
Valsartan—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000444	0.00276	CcSEcCtD
Valsartan—Cough—Triamcinolone—psoriatic arthritis	0.000444	0.00276	CcSEcCtD
Valsartan—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00044	0.00274	CcSEcCtD
Valsartan—Myalgia—Triamcinolone—psoriatic arthritis	0.000433	0.0027	CcSEcCtD
Valsartan—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000432	0.00269	CcSEcCtD
Valsartan—Myalgia—Methylprednisolone—psoriatic arthritis	0.000432	0.00269	CcSEcCtD
Valsartan—Anxiety—Methylprednisolone—psoriatic arthritis	0.000431	0.00268	CcSEcCtD
Valsartan—Infestation NOS—Methotrexate—psoriatic arthritis	0.00043	0.00268	CcSEcCtD
Valsartan—Infestation—Methotrexate—psoriatic arthritis	0.00043	0.00268	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000429	0.00267	CcSEcCtD
Valsartan—Dry mouth—Triamcinolone—psoriatic arthritis	0.000423	0.00264	CcSEcCtD
Valsartan—Renal failure—Methotrexate—psoriatic arthritis	0.000422	0.00263	CcSEcCtD
Valsartan—Angioedema—Dexamethasone—psoriatic arthritis	0.000422	0.00262	CcSEcCtD
Valsartan—Angioedema—Betamethasone—psoriatic arthritis	0.000422	0.00262	CcSEcCtD
Valsartan—Angiopathy—Prednisone—psoriatic arthritis	0.000419	0.00261	CcSEcCtD
Valsartan—Immune system disorder—Prednisone—psoriatic arthritis	0.000417	0.0026	CcSEcCtD
Valsartan—Oedema—Triamcinolone—psoriatic arthritis	0.000415	0.00258	CcSEcCtD
Valsartan—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000415	0.00258	CcSEcCtD
Valsartan—Vertigo—Betamethasone—psoriatic arthritis	0.000415	0.00258	CcSEcCtD
Valsartan—Vertigo—Dexamethasone—psoriatic arthritis	0.000415	0.00258	CcSEcCtD
Valsartan—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000414	0.00258	CcSEcCtD
Valsartan—Syncope—Dexamethasone—psoriatic arthritis	0.000414	0.00258	CcSEcCtD
Valsartan—Syncope—Betamethasone—psoriatic arthritis	0.000414	0.00258	CcSEcCtD
Valsartan—Infection—Triamcinolone—psoriatic arthritis	0.000412	0.00257	CcSEcCtD
Valsartan—Infection—Methylprednisolone—psoriatic arthritis	0.000411	0.00256	CcSEcCtD
Valsartan—Shock—Triamcinolone—psoriatic arthritis	0.000408	0.00254	CcSEcCtD
Valsartan—Insomnia—Prednisolone—psoriatic arthritis	0.000408	0.00254	CcSEcCtD
Valsartan—Alopecia—Prednisone—psoriatic arthritis	0.000408	0.00254	CcSEcCtD
Valsartan—Shock—Methylprednisolone—psoriatic arthritis	0.000407	0.00254	CcSEcCtD
Valsartan—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000406	0.00253	CcSEcCtD
Valsartan—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000406	0.00252	CcSEcCtD
Valsartan—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000406	0.00252	CcSEcCtD
Valsartan—Epistaxis—Methotrexate—psoriatic arthritis	0.000405	0.00252	CcSEcCtD
Valsartan—Paraesthesia—Prednisolone—psoriatic arthritis	0.000405	0.00252	CcSEcCtD
Valsartan—Mental disorder—Prednisone—psoriatic arthritis	0.000404	0.00252	CcSEcCtD
Valsartan—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000402	0.0025	CcSEcCtD
Valsartan—Malnutrition—Prednisone—psoriatic arthritis	0.000402	0.0025	CcSEcCtD
Valsartan—Myalgia—Dexamethasone—psoriatic arthritis	0.000393	0.00245	CcSEcCtD
Valsartan—Myalgia—Betamethasone—psoriatic arthritis	0.000393	0.00245	CcSEcCtD
Valsartan—Anxiety—Dexamethasone—psoriatic arthritis	0.000391	0.00244	CcSEcCtD
Valsartan—Anxiety—Betamethasone—psoriatic arthritis	0.000391	0.00244	CcSEcCtD
Valsartan—Haemoglobin—Methotrexate—psoriatic arthritis	0.000388	0.00241	CcSEcCtD
Valsartan—Hypotension—Methylprednisolone—psoriatic arthritis	0.000387	0.00241	CcSEcCtD
Valsartan—Hepatitis—Methotrexate—psoriatic arthritis	0.000386	0.0024	CcSEcCtD
Valsartan—Haemorrhage—Methotrexate—psoriatic arthritis	0.000386	0.0024	CcSEcCtD
Valsartan—Pharyngitis—Methotrexate—psoriatic arthritis	0.000383	0.00238	CcSEcCtD
Valsartan—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000381	0.00237	CcSEcCtD
Valsartan—Vision blurred—Prednisone—psoriatic arthritis	0.000379	0.00236	CcSEcCtD
Valsartan—Urethral disorder—Methotrexate—psoriatic arthritis	0.000378	0.00235	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000378	0.00235	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000377	0.00235	CcSEcCtD
Valsartan—Oedema—Betamethasone—psoriatic arthritis	0.000377	0.00234	CcSEcCtD
Valsartan—Oedema—Dexamethasone—psoriatic arthritis	0.000377	0.00234	CcSEcCtD
Valsartan—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000377	0.00234	CcSEcCtD
Valsartan—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000377	0.00234	CcSEcCtD
Valsartan—Insomnia—Triamcinolone—psoriatic arthritis	0.000375	0.00234	CcSEcCtD
Valsartan—Insomnia—Methylprednisolone—psoriatic arthritis	0.000375	0.00233	CcSEcCtD
Valsartan—Infection—Dexamethasone—psoriatic arthritis	0.000374	0.00233	CcSEcCtD
Valsartan—Infection—Betamethasone—psoriatic arthritis	0.000374	0.00233	CcSEcCtD
Valsartan—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000373	0.00232	CcSEcCtD
Valsartan—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000372	0.00231	CcSEcCtD
Valsartan—Shock—Dexamethasone—psoriatic arthritis	0.000371	0.00231	CcSEcCtD
Valsartan—Shock—Betamethasone—psoriatic arthritis	0.000371	0.00231	CcSEcCtD
Valsartan—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00037	0.0023	CcSEcCtD
Valsartan—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000369	0.0023	CcSEcCtD
Valsartan—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000369	0.0023	CcSEcCtD
Valsartan—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000369	0.0023	CcSEcCtD
Valsartan—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000369	0.0023	CcSEcCtD
Valsartan—Angioedema—Prednisone—psoriatic arthritis	0.000367	0.00229	CcSEcCtD
Valsartan—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000365	0.00227	CcSEcCtD
Valsartan—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000365	0.00227	CcSEcCtD
Valsartan—Vertigo—Prednisone—psoriatic arthritis	0.000361	0.00225	CcSEcCtD
Valsartan—Syncope—Prednisone—psoriatic arthritis	0.00036	0.00224	CcSEcCtD
Valsartan—Anorexia—Betamethasone—psoriatic arthritis	0.000359	0.00223	CcSEcCtD
Valsartan—Anorexia—Dexamethasone—psoriatic arthritis	0.000359	0.00223	CcSEcCtD
Valsartan—Urticaria—Prednisolone—psoriatic arthritis	0.000359	0.00223	CcSEcCtD
Valsartan—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000358	0.00223	CcSEcCtD
Valsartan—Fatigue—Triamcinolone—psoriatic arthritis	0.000358	0.00223	CcSEcCtD
Valsartan—Fatigue—Methylprednisolone—psoriatic arthritis	0.000357	0.00222	CcSEcCtD
Valsartan—Loss of consciousness—Prednisone—psoriatic arthritis	0.000353	0.0022	CcSEcCtD
Valsartan—Hypotension—Dexamethasone—psoriatic arthritis	0.000352	0.00219	CcSEcCtD
Valsartan—Hypotension—Betamethasone—psoriatic arthritis	0.000352	0.00219	CcSEcCtD
Valsartan—Angiopathy—Methotrexate—psoriatic arthritis	0.00035	0.00218	CcSEcCtD
Valsartan—Immune system disorder—Methotrexate—psoriatic arthritis	0.000348	0.00217	CcSEcCtD
Valsartan—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000348	0.00216	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000343	0.00214	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000343	0.00214	CcSEcCtD
Valsartan—Myalgia—Prednisone—psoriatic arthritis	0.000342	0.00213	CcSEcCtD
Valsartan—Arthralgia—Prednisone—psoriatic arthritis	0.000342	0.00213	CcSEcCtD
Valsartan—Anxiety—Prednisone—psoriatic arthritis	0.000341	0.00212	CcSEcCtD
Valsartan—Alopecia—Methotrexate—psoriatic arthritis	0.000341	0.00212	CcSEcCtD
Valsartan—Insomnia—Dexamethasone—psoriatic arthritis	0.000341	0.00212	CcSEcCtD
Valsartan—Insomnia—Betamethasone—psoriatic arthritis	0.000341	0.00212	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00034	0.00212	CcSEcCtD
Valsartan—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000339	0.00211	CcSEcCtD
Valsartan—Paraesthesia—Betamethasone—psoriatic arthritis	0.000338	0.00211	CcSEcCtD
Valsartan—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000338	0.00211	CcSEcCtD
Valsartan—Mental disorder—Methotrexate—psoriatic arthritis	0.000338	0.0021	CcSEcCtD
Valsartan—Malnutrition—Methotrexate—psoriatic arthritis	0.000336	0.00209	CcSEcCtD
Valsartan—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000333	0.00207	CcSEcCtD
Valsartan—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000332	0.00206	CcSEcCtD
Valsartan—Dyspepsia—Betamethasone—psoriatic arthritis	0.000332	0.00206	CcSEcCtD
Valsartan—Urticaria—Triamcinolone—psoriatic arthritis	0.00033	0.00205	CcSEcCtD
Valsartan—Urticaria—Methylprednisolone—psoriatic arthritis	0.000329	0.00205	CcSEcCtD
Valsartan—Dysgeusia—Methotrexate—psoriatic arthritis	0.000329	0.00205	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000328	0.00204	CcSEcCtD
Valsartan—Oedema—Prednisone—psoriatic arthritis	0.000328	0.00204	CcSEcCtD
Valsartan—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000327	0.00204	CcSEcCtD
Valsartan—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000327	0.00204	CcSEcCtD
Valsartan—Decreased appetite—Betamethasone—psoriatic arthritis	0.000327	0.00204	CcSEcCtD
Valsartan—Infection—Prednisone—psoriatic arthritis	0.000326	0.00203	CcSEcCtD
Valsartan—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000325	0.00202	CcSEcCtD
Valsartan—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000325	0.00202	CcSEcCtD
Valsartan—Back pain—Methotrexate—psoriatic arthritis	0.000325	0.00202	CcSEcCtD
Valsartan—Fatigue—Dexamethasone—psoriatic arthritis	0.000325	0.00202	CcSEcCtD
Valsartan—Fatigue—Betamethasone—psoriatic arthritis	0.000325	0.00202	CcSEcCtD
Valsartan—Shock—Prednisone—psoriatic arthritis	0.000323	0.00201	CcSEcCtD
Valsartan—Nervous system disorder—Prednisone—psoriatic arthritis	0.000322	0.002	CcSEcCtD
Valsartan—Skin disorder—Prednisone—psoriatic arthritis	0.000319	0.00198	CcSEcCtD
Valsartan—Vision blurred—Methotrexate—psoriatic arthritis	0.000317	0.00197	CcSEcCtD
Valsartan—Anorexia—Prednisone—psoriatic arthritis	0.000313	0.00195	CcSEcCtD
Valsartan—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000308	0.00192	CcSEcCtD
Valsartan—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000308	0.00192	CcSEcCtD
Valsartan—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000306	0.0019	CcSEcCtD
Valsartan—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000305	0.0019	CcSEcCtD
Valsartan—Vertigo—Methotrexate—psoriatic arthritis	0.000302	0.00188	CcSEcCtD
Valsartan—Urticaria—Dexamethasone—psoriatic arthritis	0.000299	0.00186	CcSEcCtD
Valsartan—Urticaria—Betamethasone—psoriatic arthritis	0.000299	0.00186	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000299	0.00186	CcSEcCtD
Valsartan—Dizziness—Prednisolone—psoriatic arthritis	0.000298	0.00186	CcSEcCtD
Valsartan—Asthenia—Triamcinolone—psoriatic arthritis	0.000298	0.00185	CcSEcCtD
Valsartan—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000298	0.00185	CcSEcCtD
Valsartan—Abdominal pain—Betamethasone—psoriatic arthritis	0.000298	0.00185	CcSEcCtD
Valsartan—Asthenia—Methylprednisolone—psoriatic arthritis	0.000297	0.00185	CcSEcCtD
Valsartan—Insomnia—Prednisone—psoriatic arthritis	0.000297	0.00185	CcSEcCtD
Valsartan—Paraesthesia—Prednisone—psoriatic arthritis	0.000294	0.00183	CcSEcCtD
Valsartan—Pruritus—Triamcinolone—psoriatic arthritis	0.000294	0.00183	CcSEcCtD
Valsartan—Cough—Methotrexate—psoriatic arthritis	0.000293	0.00182	CcSEcCtD
Valsartan—Pruritus—Methylprednisolone—psoriatic arthritis	0.000293	0.00182	CcSEcCtD
Valsartan—Dyspepsia—Prednisone—psoriatic arthritis	0.000289	0.0018	CcSEcCtD
Valsartan—Myalgia—Methotrexate—psoriatic arthritis	0.000286	0.00178	CcSEcCtD
Valsartan—Chest pain—Methotrexate—psoriatic arthritis	0.000286	0.00178	CcSEcCtD
Valsartan—Arthralgia—Methotrexate—psoriatic arthritis	0.000286	0.00178	CcSEcCtD
Valsartan—Decreased appetite—Prednisone—psoriatic arthritis	0.000285	0.00177	CcSEcCtD
Valsartan—Rash—Prednisolone—psoriatic arthritis	0.000285	0.00177	CcSEcCtD
Valsartan—Dermatitis—Prednisolone—psoriatic arthritis	0.000284	0.00177	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000284	0.00177	CcSEcCtD
Valsartan—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000283	0.00176	CcSEcCtD
Valsartan—Fatigue—Prednisone—psoriatic arthritis	0.000283	0.00176	CcSEcCtD
Valsartan—Headache—Prednisolone—psoriatic arthritis	0.000283	0.00176	CcSEcCtD
Valsartan—Constipation—Prednisone—psoriatic arthritis	0.00028	0.00175	CcSEcCtD
Valsartan—Dizziness—Triamcinolone—psoriatic arthritis	0.000274	0.00171	CcSEcCtD
Valsartan—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000274	0.00171	CcSEcCtD
Valsartan—Dizziness—Methylprednisolone—psoriatic arthritis	0.000274	0.0017	CcSEcCtD
Valsartan—Infection—Methotrexate—psoriatic arthritis	0.000272	0.0017	CcSEcCtD
Valsartan—Asthenia—Betamethasone—psoriatic arthritis	0.00027	0.00168	CcSEcCtD
Valsartan—Asthenia—Dexamethasone—psoriatic arthritis	0.00027	0.00168	CcSEcCtD
Valsartan—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000269	0.00167	CcSEcCtD
Valsartan—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000268	0.00167	CcSEcCtD
Valsartan—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000268	0.00167	CcSEcCtD
Valsartan—Nausea—Prednisolone—psoriatic arthritis	0.000268	0.00167	CcSEcCtD
Valsartan—Pruritus—Dexamethasone—psoriatic arthritis	0.000266	0.00166	CcSEcCtD
Valsartan—Pruritus—Betamethasone—psoriatic arthritis	0.000266	0.00166	CcSEcCtD
Valsartan—Skin disorder—Methotrexate—psoriatic arthritis	0.000266	0.00166	CcSEcCtD
Valsartan—Vomiting—Triamcinolone—psoriatic arthritis	0.000264	0.00164	CcSEcCtD
Valsartan—Vomiting—Methylprednisolone—psoriatic arthritis	0.000263	0.00164	CcSEcCtD
Valsartan—Rash—Triamcinolone—psoriatic arthritis	0.000262	0.00163	CcSEcCtD
Valsartan—Dermatitis—Triamcinolone—psoriatic arthritis	0.000261	0.00163	CcSEcCtD
Valsartan—Anorexia—Methotrexate—psoriatic arthritis	0.000261	0.00163	CcSEcCtD
Valsartan—Rash—Methylprednisolone—psoriatic arthritis	0.000261	0.00163	CcSEcCtD
Valsartan—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000261	0.00162	CcSEcCtD
Valsartan—Urticaria—Prednisone—psoriatic arthritis	0.000261	0.00162	CcSEcCtD
Valsartan—Headache—Triamcinolone—psoriatic arthritis	0.00026	0.00162	CcSEcCtD
Valsartan—Headache—Methylprednisolone—psoriatic arthritis	0.000259	0.00162	CcSEcCtD
Valsartan—Abdominal pain—Prednisone—psoriatic arthritis	0.000259	0.00161	CcSEcCtD
Valsartan—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000258	0.0016	CcSEcCtD
Valsartan—Diarrhoea—Betamethasone—psoriatic arthritis	0.000258	0.0016	CcSEcCtD
Valsartan—Hypotension—Methotrexate—psoriatic arthritis	0.000256	0.00159	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00025	0.00155	CcSEcCtD
Valsartan—Dizziness—Dexamethasone—psoriatic arthritis	0.000249	0.00155	CcSEcCtD
Valsartan—Dizziness—Betamethasone—psoriatic arthritis	0.000249	0.00155	CcSEcCtD
Valsartan—Insomnia—Methotrexate—psoriatic arthritis	0.000248	0.00154	CcSEcCtD
Valsartan—Nausea—Triamcinolone—psoriatic arthritis	0.000247	0.00153	CcSEcCtD
Valsartan—Paraesthesia—Methotrexate—psoriatic arthritis	0.000246	0.00153	CcSEcCtD
Valsartan—Nausea—Methylprednisolone—psoriatic arthritis	0.000246	0.00153	CcSEcCtD
Valsartan—Dyspnoea—Methotrexate—psoriatic arthritis	0.000244	0.00152	CcSEcCtD
Valsartan—Somnolence—Methotrexate—psoriatic arthritis	0.000244	0.00152	CcSEcCtD
Valsartan—Hypersensitivity—Prednisone—psoriatic arthritis	0.000242	0.0015	CcSEcCtD
Valsartan—Dyspepsia—Methotrexate—psoriatic arthritis	0.000241	0.0015	CcSEcCtD
Valsartan—Vomiting—Dexamethasone—psoriatic arthritis	0.000239	0.00149	CcSEcCtD
Valsartan—Vomiting—Betamethasone—psoriatic arthritis	0.000239	0.00149	CcSEcCtD
Valsartan—Decreased appetite—Methotrexate—psoriatic arthritis	0.000238	0.00148	CcSEcCtD
Valsartan—Rash—Betamethasone—psoriatic arthritis	0.000237	0.00148	CcSEcCtD
Valsartan—Rash—Dexamethasone—psoriatic arthritis	0.000237	0.00148	CcSEcCtD
Valsartan—Dermatitis—Dexamethasone—psoriatic arthritis	0.000237	0.00148	CcSEcCtD
Valsartan—Dermatitis—Betamethasone—psoriatic arthritis	0.000237	0.00148	CcSEcCtD
Valsartan—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000237	0.00147	CcSEcCtD
Valsartan—Fatigue—Methotrexate—psoriatic arthritis	0.000236	0.00147	CcSEcCtD
Valsartan—Headache—Betamethasone—psoriatic arthritis	0.000236	0.00147	CcSEcCtD
Valsartan—Headache—Dexamethasone—psoriatic arthritis	0.000236	0.00147	CcSEcCtD
Valsartan—Asthenia—Prednisone—psoriatic arthritis	0.000235	0.00146	CcSEcCtD
Valsartan—Pruritus—Prednisone—psoriatic arthritis	0.000232	0.00144	CcSEcCtD
Valsartan—Diarrhoea—Prednisone—psoriatic arthritis	0.000224	0.0014	CcSEcCtD
Valsartan—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000224	0.0014	CcSEcCtD
Valsartan—Nausea—Dexamethasone—psoriatic arthritis	0.000224	0.00139	CcSEcCtD
Valsartan—Nausea—Betamethasone—psoriatic arthritis	0.000224	0.00139	CcSEcCtD
Valsartan—Urticaria—Methotrexate—psoriatic arthritis	0.000218	0.00136	CcSEcCtD
Valsartan—Dizziness—Prednisone—psoriatic arthritis	0.000217	0.00135	CcSEcCtD
Valsartan—Abdominal pain—Methotrexate—psoriatic arthritis	0.000217	0.00135	CcSEcCtD
Valsartan—Vomiting—Prednisone—psoriatic arthritis	0.000209	0.0013	CcSEcCtD
Valsartan—Rash—Prednisone—psoriatic arthritis	0.000207	0.00129	CcSEcCtD
Valsartan—Dermatitis—Prednisone—psoriatic arthritis	0.000207	0.00129	CcSEcCtD
Valsartan—Headache—Prednisone—psoriatic arthritis	0.000205	0.00128	CcSEcCtD
Valsartan—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000202	0.00126	CcSEcCtD
Valsartan—Asthenia—Methotrexate—psoriatic arthritis	0.000197	0.00122	CcSEcCtD
Valsartan—Nausea—Prednisone—psoriatic arthritis	0.000195	0.00121	CcSEcCtD
Valsartan—Pruritus—Methotrexate—psoriatic arthritis	0.000194	0.00121	CcSEcCtD
Valsartan—Diarrhoea—Methotrexate—psoriatic arthritis	0.000188	0.00117	CcSEcCtD
Valsartan—Dizziness—Methotrexate—psoriatic arthritis	0.000181	0.00113	CcSEcCtD
Valsartan—Vomiting—Methotrexate—psoriatic arthritis	0.000174	0.00108	CcSEcCtD
Valsartan—Rash—Methotrexate—psoriatic arthritis	0.000173	0.00108	CcSEcCtD
Valsartan—Dermatitis—Methotrexate—psoriatic arthritis	0.000173	0.00107	CcSEcCtD
Valsartan—Headache—Methotrexate—psoriatic arthritis	0.000172	0.00107	CcSEcCtD
Valsartan—Nausea—Methotrexate—psoriatic arthritis	0.000163	0.00101	CcSEcCtD
